Prognostic value of pretreatment smoking status for small cell lung cancer: A meta‐analysis

Abstract

Background Although tobacco exposure remains the most important risk factor of tumorigenesis of small cell lung cancer (SCLC), its prognostic value has failed to reach a consensus until now. Accordingly, we conducted a meta‐analysis to investigate the prognostic value of pretreatment smoking status (smokers vs. never‐smokers) in SCLC. Methods The four databases PubMed, Medline, Embase, and Cochrane library were searched to identify the relevant literature from the inception dates to 24 June 2020. The primary outcome was overall survival (OS), and the secondary endpoint was progression‐free survival (PFS). The hazard ratios (HRs) with 95% confidence intervals (CIs) were extracted to assess the relationship between pretreatment smoking status and patient survival. Sensitivity analysis was performed to assess the stability of the pooled results. Begg's funnel plot and Egger's test were applied to detect the publication bias. All statistical analyses were performed using RevMan V.5.3 and STATA version 15.0 software. Results A total of 27 studies involving 12 047 patients with SCLC (9137 smokers and 2910 never‐smokers) were included in this meta‐analysis. The results showed that smoking history was closely related to poorer survival outcome (OS: HR = 1.17, 95% CI: 1.12–1.23, P < 0.00001; I 2 = 0%; PFS: HR = 1.20, 95% CI: 1.06–1.35, P = 0.004; I 2 = 0%). Conclusions Smoking history should be considered as an independent poor prognostic factor for patients with SCLC. More large‐scale prospective studies are warranted to testify the prognostic value of pretreatment smoking status.

Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis

“…In non-small cell lung cancer, the incidence of the driver mutation accounts for the survival difference between male and female patients; in SCLC, this may be explained by the prevalence of smoking. A previous meta-analysis has shown that smoking history was closely related to poorer survival outcomes [ 13 ]. Despite smoking status being largely missing in the present analysis, we assumed that the survival difference based on sex could be related to the divergence of smoking status between men and women.…”

Diabetes Mellitus Is a Strong Independent Negative Prognostic Factor in Patients with Brain Metastases Treated with Radiotherapy

“…Smoking is associated with a poorer prognosis in patients with small-/non-small cell lung cancer (SCLC/NSCLC) and breast cancer [27][28][29]. Regarding hypercholesterolemia, cholesterol-lowering medication was associated with a decrease in cancer mortality in in a large meta-analysis of breast cancer patients [30].…”

Yaygın evre küçük hücreli akciğer kanserinde lenfosit/monosit oranının prognostik önemi

“…Tedavi öncesi sigara içmek, genomik profil, dolaşan tümör hücreleri, Geriatric Nutritional Risk Index, delta-like protein 3 ve serum laktat dehidrogenaz seviyeleri bildirilmiş prognostik faktörlerdendir. [3][4][5][6][7][8] Kanser gelişimi ve progresyonunda inflamasyon hücreleri ve kemokinler önemli temel prognostik belirteçlerdir. 9 Lenfositler doğal immünitenin bir parçası olarak sitotoksik hücre ölümünü tetiklemektelerdir.…”